Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial

Lancet Microbe, The - Tập 3 Số 1 - Trang e11-e20 - 2022